Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.74 USD | +4.28% | -4.91% | -15.46% |
Chart calendar Akero Therapeutics, Inc.
Upcoming events on Akero Therapeutics, Inc.
Past events on Akero Therapeutics, Inc.
04/03/2024 06:30 pm | Efruxifermin Phase 2b HARMONY Study Results Call |
29/02/2024 05:30 pm | Q4 2023 Earnings Release |
08/01/2024 11:15 pm | JPMorgan Healthcare Conference |
29/11/2023 06:00 pm | Evercore ISI HealthCONx Conference - Fireside Chat |
15/11/2023 10:30 pm | Jefferies London Healthcare Conference - Fireside Chat |
14/11/2023 01:45 am | American Association for the Study of Liver Diseases Conference - Abstract Number: 5005 |
13/11/2023 11:30 pm | American Association for the Study of Liver Diseases Conference - Abstract Number: 48626 |
13/11/2023 05:30 pm | Q3 2023 Earnings Release |
24/10/2023 09:30 pm | H.C. Wainwright NASH Investor Conference |
10/10/2023 05:30 pm | Efruxifermin Phase 2b SYMMETRY Study Results Call |
13/09/2023 06:30 pm | H.C. Wainwright Global Investment Conference |
13/09/2023 02:25 am | Morgan Stanley Global Healthcare Conference |
11/08/2023 03:30 pm | Q2 2023 Earnings Release |
23/06/2023 06:30 pm | Annual General Meeting |
07/06/2023 08:00 pm | Jefferies Global Healthcare Conference |
05/06/2023 05:30 pm | SYMMETRY Cohort D Phase 2b Trial Results Call |
15/05/2023 04:30 pm | Q1 2023 Earnings Release |
17/03/2023 04:30 pm | Q4 2022 Earnings Release |
11/01/2023 12:00 am | JP Morgan Healthcare Conference |
29/11/2022 10:40 pm | Evercore ISI HealthCONx Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | -45,7 -45,4 -0.58% | -74,1 -67,6 -9.59% | -101 -97,0 -3.96% | -115 -123 6.44% | -173 -156 -10.52% | -249 |
EBIT Million USD | Released Forecast Spread | -45,7 -45,2 -0.96% | -80,2 -70,2 -14.17% | -101 -96,9 -4.15% | -115 -125 8.11% | -173 -160 -7.93% | -240 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -43,8 -45,1 2.98% | -79,2 -69,2 -14.42% | -101 -96,8 -4.11% | -112 -125 10.33% | -152 -148 -2.85% | -230 |
Net income Million USD | Released Forecast Spread | -43,8 -45,6 4.11% | -79,2 -68,6 -15.46% | -101 -96,5 -4.47% | -112 -125 10.04% | -152 -147 -3.3% | -233 |
EPS USD | Released Forecast Spread | -2,90 -2,83 -2.41% | -2,52 -2,20 -14.49% | -2,89 -2,76 -4.88% | -2,87 -3,22 10.73% | -2,89 -2,90 0.24% | -3,94 |
Announcement Date | 16/03/20 | 16/03/21 | 25/02/22 | 17/03/23 | 29/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
EBITDA Million USD | Released Forecast Spread | -32,4 -28,0 -15.63% | -26,0 -29,0 10.21% | -27,6 | -36,1 -32,0 -12.75% | -25,4 -37,0 31.32% | -28,7 -28,0 -2.65% | -35,6 -33,0 -7.93% | -46,6 -40,0 -16.53% | -61,9 -43,0 -43.89% | -66,0 | -71,0 | -76,0 | -81,0 | |
EBIT Million USD | Released Forecast Spread | -32,4 -28,1 -15.5% | -26,1 -28,2 7.76% | -27,6 -33,8 18.35% | -36,1 -30,4 -18.82% | -25,4 -35,9 29.15% | -28,8 -29,8 3.61% | -35,6 -32,1 -10.83% | -46,6 -37,0 -25.97% | -61,9 -48,3 -28.07% | -57,9 | -59,4 | -61,9 | -68,1 | -67,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -32,4 -28,5 -13.57% | -26,0 -29,3 11.02% | -27,4 -33,8 18.9% | -35,5 -30,8 -15.29% | -23,1 -36,0 35.87% | -25,8 -30,0 13.85% | -31,1 -32,2 3.52% | -39,7 -36,0 -10.14% | -55,2 -48,0 -14.98% | -54,5 | -54,6 | -57,3 | -66,1 | |
Net income Million USD | Released Forecast Spread | -32,4 -28,1 -15.47% | -26,0 -28,2 7.83% | -27,4 -33,8 18.9% | -35,5 -30,3 -17.22% | -23,1 -35,6 35.3% | -25,8 -29,6 12.81% | -31,1 -32,2 3.52% | -39,7 -37,1 -6.77% | -55,2 -48,5 -13.89% | -54,6 | -56,2 | -58,7 | -64,9 | -68,9 |
EPS USD | Released Forecast Spread | -0,93 -0,80 -16.21% | -0,74 -0,81 8.51% | -0,77 -0,90 14.58% | -0,92 -0,72 -27.83% | -0,49 -0,80 38.44% | -0,55 -0,67 18.15% | -0,60 -0,70 13.67% | -0,71 -0,68 -4.55% | -0,99 -0,87 -13.86% | -0,95 | -0,97 | -1,01 | -1,12 | -1,21 |
Announcement Date | 25/02/22 | 06/05/22 | 05/08/22 | 04/11/22 | 17/03/23 | 15/05/23 | 11/08/23 | 13/11/23 | 29/02/24 | - | - | - | - | - |
Past sector events for Akero Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AKRO Stock
- Calendar Akero Therapeutics, Inc.